Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: Antisense, microarray, gene overexpression, and transcription factor decoy

Yoon S. Cho-Chung, Maria Nesterova, Kevin G. Becker, Rakesh Srivastava, Yun Gyu Park, Youl Nam Lee, Yee Sook Cho, Meyoung-Kon Kim, Catherine Neary, Chris Cheadle

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Expression of the RIα subunit of the cAMP-dependent protein kinase type I (PKA-I) is enhanced in human cancer cell lines, in primary tumors, in transformed cells, and in cells upon stimulation of growth. Signaling via the cAMP pathway may be complex, and the biological effects of the pathway in normal cells may depend upon the physiological state of the cells. However, results of different experimental approaches such as antisense exposure, 8-CI-cAMP treatment, and gene overexpression have shown that the inhibition of RIα/PKA-I exerts antitumor activity in a wide variety of tumor-derived cell lines examined in vitro and in vivo. cDNA microarrays have further shown that in a sequence-specific manner, RIα antisense induces alterations in the gene expression profile of cancer cells and tumors. The cluster of genes that define the "proliferation-transformation" signature are down-regulated, and those that define the "differentiation-reverse transformation" signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers, exhibiting the molecular portrait of the reverted (flat) phenotype of tumor cells. These results reveal a remarkable cellular regulation, elicited by the antisense RIα, superimposed on the regulation arising from the Watson-Crick base-pairing mechanism of action. Importantly, the blockade of both the PKA and PKC signaling pathways achieved with the CRE-transcription factor decoy inhibits tumor cell growth without harming normal cell growth. Thus, a complex circuitry of cAMP signaling comprises cAMP growth regulatory function, and deregulation of the effector molecule by this circuitry may underlie cancer genesis and tumor progression.

Original languageEnglish
Pages (from-to)22-36
Number of pages15
JournalAnnals of the New York Academy of Sciences
Volume968
DOIs
Publication statusPublished - 2002 Jan 1
Externally publishedYes

Fingerprint

Microarrays
Cyclic AMP-Dependent Protein Kinases
Tumors
Transcription Factors
Genes
Cells
Neoplasms
Cell growth
Growth
Deregulation
Cancer
Genesis
Protein
Transcription
Gene
Gene expression
Liver
Protein Kinases
Complementary DNA
Multigene Family

Keywords

  • Antisense
  • Cancer
  • cDNA microarrays
  • Growth inhibition
  • Protein kinase A
  • Transcription factor decoy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis : Antisense, microarray, gene overexpression, and transcription factor decoy. / Cho-Chung, Yoon S.; Nesterova, Maria; Becker, Kevin G.; Srivastava, Rakesh; Park, Yun Gyu; Lee, Youl Nam; Cho, Yee Sook; Kim, Meyoung-Kon; Neary, Catherine; Cheadle, Chris.

In: Annals of the New York Academy of Sciences, Vol. 968, 01.01.2002, p. 22-36.

Research output: Contribution to journalArticle

Cho-Chung, Yoon S. ; Nesterova, Maria ; Becker, Kevin G. ; Srivastava, Rakesh ; Park, Yun Gyu ; Lee, Youl Nam ; Cho, Yee Sook ; Kim, Meyoung-Kon ; Neary, Catherine ; Cheadle, Chris. / Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis : Antisense, microarray, gene overexpression, and transcription factor decoy. In: Annals of the New York Academy of Sciences. 2002 ; Vol. 968. pp. 22-36.
@article{171f27e7e4aa463d83438c79ca5ee224,
title = "Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: Antisense, microarray, gene overexpression, and transcription factor decoy",
abstract = "Expression of the RIα subunit of the cAMP-dependent protein kinase type I (PKA-I) is enhanced in human cancer cell lines, in primary tumors, in transformed cells, and in cells upon stimulation of growth. Signaling via the cAMP pathway may be complex, and the biological effects of the pathway in normal cells may depend upon the physiological state of the cells. However, results of different experimental approaches such as antisense exposure, 8-CI-cAMP treatment, and gene overexpression have shown that the inhibition of RIα/PKA-I exerts antitumor activity in a wide variety of tumor-derived cell lines examined in vitro and in vivo. cDNA microarrays have further shown that in a sequence-specific manner, RIα antisense induces alterations in the gene expression profile of cancer cells and tumors. The cluster of genes that define the {"}proliferation-transformation{"} signature are down-regulated, and those that define the {"}differentiation-reverse transformation{"} signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers, exhibiting the molecular portrait of the reverted (flat) phenotype of tumor cells. These results reveal a remarkable cellular regulation, elicited by the antisense RIα, superimposed on the regulation arising from the Watson-Crick base-pairing mechanism of action. Importantly, the blockade of both the PKA and PKC signaling pathways achieved with the CRE-transcription factor decoy inhibits tumor cell growth without harming normal cell growth. Thus, a complex circuitry of cAMP signaling comprises cAMP growth regulatory function, and deregulation of the effector molecule by this circuitry may underlie cancer genesis and tumor progression.",
keywords = "Antisense, Cancer, cDNA microarrays, Growth inhibition, Protein kinase A, Transcription factor decoy",
author = "Cho-Chung, {Yoon S.} and Maria Nesterova and Becker, {Kevin G.} and Rakesh Srivastava and Park, {Yun Gyu} and Lee, {Youl Nam} and Cho, {Yee Sook} and Meyoung-Kon Kim and Catherine Neary and Chris Cheadle",
year = "2002",
month = "1",
day = "1",
doi = "10.1111/j.1749-6632.2002.tb04324.x",
language = "English",
volume = "968",
pages = "22--36",
journal = "Annals of The Lyceum of Natural History of New York",
issn = "0890-6564",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis

T2 - Antisense, microarray, gene overexpression, and transcription factor decoy

AU - Cho-Chung, Yoon S.

AU - Nesterova, Maria

AU - Becker, Kevin G.

AU - Srivastava, Rakesh

AU - Park, Yun Gyu

AU - Lee, Youl Nam

AU - Cho, Yee Sook

AU - Kim, Meyoung-Kon

AU - Neary, Catherine

AU - Cheadle, Chris

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Expression of the RIα subunit of the cAMP-dependent protein kinase type I (PKA-I) is enhanced in human cancer cell lines, in primary tumors, in transformed cells, and in cells upon stimulation of growth. Signaling via the cAMP pathway may be complex, and the biological effects of the pathway in normal cells may depend upon the physiological state of the cells. However, results of different experimental approaches such as antisense exposure, 8-CI-cAMP treatment, and gene overexpression have shown that the inhibition of RIα/PKA-I exerts antitumor activity in a wide variety of tumor-derived cell lines examined in vitro and in vivo. cDNA microarrays have further shown that in a sequence-specific manner, RIα antisense induces alterations in the gene expression profile of cancer cells and tumors. The cluster of genes that define the "proliferation-transformation" signature are down-regulated, and those that define the "differentiation-reverse transformation" signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers, exhibiting the molecular portrait of the reverted (flat) phenotype of tumor cells. These results reveal a remarkable cellular regulation, elicited by the antisense RIα, superimposed on the regulation arising from the Watson-Crick base-pairing mechanism of action. Importantly, the blockade of both the PKA and PKC signaling pathways achieved with the CRE-transcription factor decoy inhibits tumor cell growth without harming normal cell growth. Thus, a complex circuitry of cAMP signaling comprises cAMP growth regulatory function, and deregulation of the effector molecule by this circuitry may underlie cancer genesis and tumor progression.

AB - Expression of the RIα subunit of the cAMP-dependent protein kinase type I (PKA-I) is enhanced in human cancer cell lines, in primary tumors, in transformed cells, and in cells upon stimulation of growth. Signaling via the cAMP pathway may be complex, and the biological effects of the pathway in normal cells may depend upon the physiological state of the cells. However, results of different experimental approaches such as antisense exposure, 8-CI-cAMP treatment, and gene overexpression have shown that the inhibition of RIα/PKA-I exerts antitumor activity in a wide variety of tumor-derived cell lines examined in vitro and in vivo. cDNA microarrays have further shown that in a sequence-specific manner, RIα antisense induces alterations in the gene expression profile of cancer cells and tumors. The cluster of genes that define the "proliferation-transformation" signature are down-regulated, and those that define the "differentiation-reverse transformation" signature are up-regulated in antisense-treated cancer cells and tumors, but not in host livers, exhibiting the molecular portrait of the reverted (flat) phenotype of tumor cells. These results reveal a remarkable cellular regulation, elicited by the antisense RIα, superimposed on the regulation arising from the Watson-Crick base-pairing mechanism of action. Importantly, the blockade of both the PKA and PKC signaling pathways achieved with the CRE-transcription factor decoy inhibits tumor cell growth without harming normal cell growth. Thus, a complex circuitry of cAMP signaling comprises cAMP growth regulatory function, and deregulation of the effector molecule by this circuitry may underlie cancer genesis and tumor progression.

KW - Antisense

KW - Cancer

KW - cDNA microarrays

KW - Growth inhibition

KW - Protein kinase A

KW - Transcription factor decoy

UR - http://www.scopus.com/inward/record.url?scp=18444397450&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18444397450&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2002.tb04324.x

DO - 10.1111/j.1749-6632.2002.tb04324.x

M3 - Article

C2 - 12119265

AN - SCOPUS:18444397450

VL - 968

SP - 22

EP - 36

JO - Annals of The Lyceum of Natural History of New York

JF - Annals of The Lyceum of Natural History of New York

SN - 0890-6564

ER -